Literature DB >> 18695677

Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression.

J Tang1, X Yang, X Liu.   

Abstract

Polo-like kinase 1 (Plk1), the best characterized member of the mammalian polo-like kinase family, is well regulated throughout the cell cycle at the protein expression level. Moreover, it is known that Plk1 kinase activity is also regulated at the post-translational level through phosphorylation. However, the upstream kinases of Plk1 have not been identified. Although the involvement of the p38 MAP kinase pathway in cellular responses to stress has been well documented, the role of this pathway in normal cell cycle progression is unclear. Here, we show that phosphorylated p38 and MAP kinase-activated protein kinase 2 (MK2) are colocalized with Plk1 to the spindle poles during prophase and metaphase. Specific depletion of various members of the p38 MAP kinase pathway by the use of RNA interference revealed that the pathway is required for mitotic progression under normal growth conditions. Furthermore, MK2 directly phosphorylates Ser326 of Plk1. Ectopic expression of Plk1-S326A completely blocked cells at mitosis, likely due to the defect of bipolar spindle formation and subsequent activation of the spindle checkpoint. Only Plk1-S326E, but not the Plk1-S326A, efficiently rescued the p38 or MK2-depletion-induced mitotic defects, further solidifying the requirement of S326 phosphorylation during mitotic progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695677      PMCID: PMC2678890          DOI: 10.1038/onc.2008.262

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Activation of p38 mitogen-activated protein kinase during normal mitosis in the developing retina.

Authors:  C B L Campos; P A Bédard; R Linden
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 2.  Polo-like kinases and the orchestration of cell division.

Authors:  Francis A Barr; Herman H W Silljé; Erich A Nigg
Journal:  Nat Rev Mol Cell Biol       Date:  2004-06       Impact factor: 94.444

3.  PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas.

Authors:  R Knecht; C Oberhauser; K Strebhardt
Journal:  Int J Cancer       Date:  2000-11-20       Impact factor: 7.396

4.  The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae.

Authors:  M Shirayama; W Zachariae; R Ciosk; K Nasmyth
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

5.  Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells.

Authors:  Xiaoqi Liu; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

Review 6.  p38 MAP kinase: a convergence point in cancer therapy.

Authors:  James M Olson; Andrew R Hallahan
Journal:  Trends Mol Med       Date:  2004-03       Impact factor: 11.951

7.  Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA.

Authors:  Xiaoqi Liu; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

8.  Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5.

Authors:  R M Golsteyn; S J Schultz; J Bartek; A Ziemiecki; T Ried; E A Nigg
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

9.  Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.

Authors:  Alexei Mikhailov; Mio Shinohara; Conly L Rieder
Journal:  J Cell Biol       Date:  2004-08-09       Impact factor: 10.539

10.  Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells.

Authors:  Catherine Lindon; Jonathon Pines
Journal:  J Cell Biol       Date:  2004-01-19       Impact factor: 10.539

View more
  23 in total

1.  Stress-stimulated mitogen-activated protein kinases control the stability and activity of the Cdt1 DNA replication licensing factor.

Authors:  Srikripa Chandrasekaran; Ting Xu Tan; Jonathan R Hall; Jeanette Gowen Cook
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 2.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

3.  Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression.

Authors:  Kalyan Dulla; Henrik Daub; Renate Hornberger; Erich A Nigg; Roman Körner
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

4.  SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress.

Authors:  Takanori Nakamura; Haruo Saito; Mutsuhiro Takekawa
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.

Authors:  Leo Studach; Wen-Horng Wang; Gregory Weber; Jiabin Tang; Ronald L Hullinger; Raphael Malbrue; Xiaoqi Liu; Ourania Andrisani
Journal:  J Biol Chem       Date:  2010-07-12       Impact factor: 5.157

6.  SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function.

Authors:  Donghua Wen; Jianguo Wu; Lei Wang; Zheng Fu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

7.  MAPK-activated protein kinase 2 is required for mouse meiotic spindle assembly and kinetochore-microtubule attachment.

Authors:  Ju Yuan; Bao-Zeng Xu; Shu-Tao Qi; Jing-Shan Tong; Liang Wei; Mo Li; Ying-Chun Ouyang; Yi Hou; Heide Schatten; Qing-Yuan Sun
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

8.  P38 mitogen-activated protein kinase activity is required during mitosis for timely satisfaction of the mitotic checkpoint but not for the fidelity of chromosome segregation.

Authors:  Kyunghee Lee; Alison E Kenny; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

9.  A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer.

Authors:  Bin Liu; Lei Yang; Binfang Huang; Mei Cheng; Hui Wang; Yinyan Li; Dongsheng Huang; Jian Zheng; Qingchu Li; Xin Zhang; Weidong Ji; Yifeng Zhou; Jiachun Lu
Journal:  Am J Hum Genet       Date:  2012-08-10       Impact factor: 11.025

10.  Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.

Authors:  Jeremy Karlin; Jasmine Allen; Syed F Ahmad; Gareth Hughes; Victoria Sheridan; Rajesh Odedra; Paul Farrington; Elaine B Cadogan; Lucy C Riches; Antonio Garcia-Trinidad; Andrew G Thomason; Bhavika Patel; Jennifer Vincent; Alan Lau; Kurt G Pike; Thomas A Hunt; Amrita Sule; Nicholas C K Valerie; Laura Biddlestone-Thorpe; Jenna Kahn; Jason M Beckta; Nitai Mukhopadhyay; Bernard Barlaam; Sebastien L Degorce; Jason Kettle; Nicola Colclough; Joanne Wilson; Aaron Smith; Ian P Barrett; Li Zheng; Tianwei Zhang; Yingchun Wang; Kan Chen; Martin Pass; Stephen T Durant; Kristoffer Valerie
Journal:  Mol Cancer Ther       Date:  2018-05-16       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.